Resonacle: Bridging The Gap Between Client Needs & Talent Acquisition

Greejesh Singh, Founder & CEO

Greejesh Singh

Founder & CEO

The Indian pharmaceutical industry is witnessing a remarkable surge, fueled by the escalating demand for specialized talent, necessitating reliance on recruitment services. However, the pharmaceutical recruitment sector faces several notable challenges. One of the primary obstacles is sourcing suitable candidates for high-level positions. As India emerges as a significant player in the global pharmaceutical market, companies are vying for top talent to maintain their competitive edge. This intense competition exacerbates the difficulty of finding qualified candidates, especially for leadership roles where specific technical expertise and industry experience are paramount. In addition, regulatory changes, technological advancements, and evolving market trends continually reshape the sector, necessitating adaptability and agility in recruitment strategies. Staying abreast of these changes and proactively adjusting recruitment methodologies to align with emerging trends is crucial for success in this ever-evolving sector. Amidst this dynamic landscape, Resonacle emerges as a dedicated organization catering exclusively to the pharmaceutical and healthcare domains.

Resonacle is one of the premier consultancy firms that provides bespoke recruitment solutions tailored specifically for the pharmaceutical and healthcare industries. Founded by industry experts with extensive experience across research and development (R&D), manufacturing, and HR, the company epitomizes a strategic approach to talent acquisition in the pharmaceutical sector. “As a leader in our field, we excel in matching talent with opportunities across all levels within the pharmaceutical sector,” says Greejesh Singh, Founder and CEO of Resonacle. “To date, we have successfully placed over 6000 individuals, each contributing significantly to their career advancement and the industry as a whole," Greejesh further adds.

Robust Network & Recruitment Methodology

Resonacle’s raison d'etre is to address the shortcomings prevalent in traditional recruitment practices, offering a bespoke solution tailored to the unique needs of the pharmaceutical industry. It understands the nuances of the Indian pharmaceutical sector with distinct hiring parameters and cultural considerations. Leveraging 10 years of industry experience, the company meticulously maps companies based on turnover and cultural alignment, focusing on organizations within the 500 to 10,000+ crore bracket where candidates are most likely to excel.

Resonacle’s rigorous screening process begins with a comprehensive checklist tailored to the client’s technical specifications. Candidates must meet stringent criteria, with only those who excel across key parameters progressing to the next stage. The experienced professionals conduct thorough video and online interviews, ensuring that only the most suitable candidates advance to the final round. At this stage, candidates undergo a meticulous evaluation process, where Resonacle delves into their past performance and market feedback to provide a comprehensive two-page evaluation report. This report, valued by clients for its depth and insight, goes beyond the confines of a traditional CV, offering invaluable information to aid in their decision-making process.

Rather than solely adhering to budgetary constraints, Resonacle takes a consultative approach, thoroughly understanding the client’s requirements

Greejesh Singh, Founder & CEO

The company maintains a vast database of over two lakh individuals within the pharmaceutical sector, meticulously tracking their career trajectories and any relevant industry developments. By leveraging this wealth of data and its robust methodology, Resonacle ensures optimal candidate-company alignment and long-term success. Its core ethos revolves around an in-depth understanding of the pharmaceutical landscape, underpinned by a team with hands-on experience in the industry’s technical intricacies. Recognizing the specialized nature of pharmaceutical operations—from R&D to manufacturing—the team comprises seasoned professionals who seamlessly bridge the gap between client needs and talent acquisition.

Resonacle employs stringent measures to safeguard confidentiality throughout the recruitment cycle. Recruiters assigned to confidential roles operate with limited visibility and are unaware of their client organization. Leveraging dedicated Applicant Tracking System (ATS) software, access to candidate profiles is restricted solely to the assigned recruiter, ensuring confidentiality at every stage. The rationale behind meticulous confidentiality measures stems from the intimate nature of the pharmaceutical industry, where industry dynamics are closely intertwined. A breach of confidentiality, especially concerning executive-level positions, carries significant ramifications, potentially disrupting organizational continuity and revenue streams. Resonacle’s commitment to privacy extends beyond internal protocols to encompass candidate interactions. Applicants remain unaware of the hiring organization until their profile receives client approval, underscoring its unwavering dedication to discretion.

Rather than solely adhering to budgetary constraints, Resonacle takes a consultative approach, thoroughly understanding the client’s requirements. When market insights reveal that a candidate with a lower salary expectation can proficiently fulfill the role, Resonacle transparently presents this alternative to the client, prioritizing suitability over commercial interests. Furthermore, the company conducts discreet reference checks, eschewing conventional methods reliant on references provided by the candidate. Leveraging its extensive network within the industry, it independently contacts previous supervisors and colleagues to glean a holistic understanding of the candidate’s capabilities and work ethic.

In addition to recruitment services, Resonacle goes above and beyond to assist clients in navigating market dynamics and industry challenges. This includes furnishing clients with invaluable market intelligence, such as competitor analysis and insights into prevailing industry trends. Moreover, Resonacle extends support to clients facing workforce restructuring, aiding in CV optimization for affected employees and devising strategic hiring plans.

Resonacle adeptly navigates the complexities of talent acquisition using sophisticated software enriched with artificial intelligence. With an unwavering commitment to staying abreast of industry trends and insights, it diligently scours diverse sources for market intelligence. This includes active engagement with prestigious institutes, industry conferences, and meticulous analysis of global market dynamics influencing the Indian pharmaceutical landscape. Driven by a shared vision of attaining preeminence in pharmaceutical recruitment, Resonacle comprises a dedicated team of 35+ individuals impassioned by the prospect of facilitating talent acquisition within the pharmaceutical sector. Their collective zeal and expertise position Resonacle as a formidable force poised to realize its ambition of becoming India’s foremost pharmaceutical hiring firm within the next two years.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.